EZH2 and neoplasm: Similar to the NDG model, the combination of EZH2-92aa inhibition and NK cell treatment substantially reduced the tumour volume and prolonged survival (Fig. 7g, h); however, the prolongation was not as apparent as in the NDG model, thus suggesting the presence of additional immunosuppressive factors from the TME.